Bamco Inc. NY Purchases Shares of 1,787,600 Waystar Holding Corp. $WAY

Bamco Inc. NY bought a new position in Waystar Holding Corp. (NASDAQ:WAY - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 1,787,600 shares of the company's stock, valued at approximately $36,699,000. Bamco Inc. NY owned 0.93% of Waystar at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Royal Bank of Canada lifted its position in Waystar by 11.3% during the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company's stock worth $808,000 after buying an additional 2,195 shares in the last quarter. AQR Capital Management LLC acquired a new stake in Waystar during the 1st quarter worth approximately $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Waystar by 91.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company's stock valued at $1,753,000 after acquiring an additional 22,364 shares during the period. NewEdge Advisors LLC bought a new stake in Waystar in the 1st quarter valued at about $234,000. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Waystar by 13.4% in the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company's stock valued at $27,918,000 after buying an additional 88,256 shares during the period.

Analysts Set New Price Targets

WAY has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $39.00 price target on shares of Waystar in a research report on Friday, July 31st. Weiss Ratings cut shares of Waystar from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, June 24th. KeyCorp reaffirmed an "overweight" rating on shares of Waystar in a research note on Friday, July 31st. UBS Group decreased their price target on Waystar from $37.00 to $33.00 and set a "buy" rating for the company in a report on Thursday, July 30th. Finally, Raymond James Financial reiterated a "strong-buy" rating and issued a $32.00 target price on shares of Waystar in a report on Thursday, April 30th. Three research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $35.00.

Key Waystar News

Here are the key news stories impacting Waystar this week:

• Positive Sentiment: Waystar launched new AltitudeAI agentic capabilities designed to autonomously execute revenue-cycle tasks, including claims processing, denial management, documentation, and patient billing. The company says the tools connect AI-generated insights directly to action, potentially improving provider efficiency and strengthening long-term revenue growth. Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
• Positive Sentiment: Coverage of the product rollout highlights Waystar’s expansion of AI-powered tools across claims, denials, and revenue-cycle documentation. Successful adoption could increase customer value, support pricing power, and differentiate Waystar in healthcare payment software. Waystar expands AI-powered agentic revenue cycle tools
• Positive Sentiment: Needham reaffirmed its Buy rating and set a $33 price target, implying substantial upside from the referenced stock level. The endorsement may reinforce investor confidence in Waystar’s growth and AI strategy. Needham rating report
• Positive Sentiment: Waystar announced two executive leadership appointments intended to accelerate innovation, client adoption, and durable growth, adding support to management’s autonomous-revenue-cycle strategy. Waystar Expands Executive Leadership to Accelerate Innovation and Growth
• Neutral Sentiment: Waystar’s analyst/investor-day transcript and presentation provide additional detail on its strategy, but the supplied reports do not identify specific new financial guidance or targets. Waystar Analyst/Investor Day Transcript
• Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day ratio, but the figures include an invalid percentage-change calculation and appear unreliable, offering little usable signal for investors.

Waystar Price Performance

Shares of NASDAQ WAY opened at $24.17 on Thursday. The firm's 50-day simple moving average is $22.58 and its 200 day simple moving average is $22.66. Waystar Holding Corp. has a fifty-two week low of $17.26 and a fifty-two week high of $41.47. The stock has a market cap of $4.63 billion, a price-to-earnings ratio of 34.53, a PEG ratio of 0.94 and a beta of 0.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.85 and a current ratio of 1.85.

Waystar (NASDAQ:WAY - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.03. Waystar had a return on equity of 7.03% and a net margin of 11.18%.The business had revenue of $319.67 million for the quarter, compared to analysts' expectations of $316.21 million. During the same period last year, the business earned $0.36 EPS. The business's revenue was up 18.1% on a year-over-year basis. As a group, research analysts anticipate that Waystar Holding Corp. will post 1.47 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Waystar news, CEO Matthew J. Hawkins sold 60,038 shares of the company's stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $25.01, for a total value of $1,501,550.38. Following the completion of the transaction, the chief executive officer owned 1,835,081 shares in the company, valued at $45,895,375.81. This represents a 3.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 3.50% of the company's stock.

Waystar Profile

Waystar NASDAQ: WAY is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source